Produktbild
Inman, Robert (Director Spondylitis Program, University Health Network, Professor of Medicine and Immunology, University of Toronto, Toronto, Canada) (Hrsg.)

Oxford Textbook of Axial Spondyloarthritis

Buch

Part of the Oxford Textbooks in Rheumatology series, this volume will cover the significant recent advances in the genetics, classification, and treatment of Axial Spondyloarthritis, making this text a timely addition to the medical literature.

CHF 189.00

Preise inkl. MwSt. und Versandkosten (Portofrei ab CHF 40.00)

Versandfertig innerhalb 1-3 Werktagen

Produktdetails


Weitere Autoren: Sieper, Joachim (Medical Department I. Rheumatology, Charite University Hospital, Campus Benjamin Franklin, Berlin, Germany) (Hrsg.)
  • ISBN: 978-0-19-873444-4
  • EAN: 9780198734444
  • Produktnummer: 22182721
  • Verlag: Oxford University Press
  • Sprache: Englisch
  • Erscheinungsjahr: 2016
  • Seitenangabe: 336 S.
  • Masse: H28.1 cm x B22.7 cm x D1.9 cm 1'072 g
  • Gewicht: 1072
  • Sonstiges: Professional & Vocational

Über den Autor


Robert D. Inman completed his undergraduate degree at Yale University, and his medical degree at McMaster University. He did his training in Internal Medicine at Vanderbilt University and his fellowship in Rheumatology at Cornell University, based at the Hospital for Special Surgery. He worked as a research fellow at the Hammersmith Hospital in London, then was appointed Assistant Professor of Medicine at Cornell University. He moved to the University of Torontowhere he was appointed Professor in the Departments of Medicine and Immunology. He was Director of Rheumatology at the University of Toronto 1991-2002. Dr Inman is currently Director of the Arthritis Center of Excellence at the University Health Network, Director of the Spondylitis Program at Toronto Western Hospital, and Deputy Physician in Chief, Research at University Health Network.Joachim Sieper is Head of the Department of Rheumatology at the Charite University Hospital, Berlin, Germany. Prof. Sieper was a Full member of the Medicines Commission 2002-2010, and has been an Extraordinary member of the Drug Commission since 2011.

Bewertungen


0 von 0 Bewertungen

Geben Sie eine Bewertung ab!

Teilen Sie Ihre Erfahrungen mit dem Produkt mit anderen Kunden.